Krystal Biotech, Inc. Peer Comparison
Metric | Value | Ranking | ||||||
---|---|---|---|---|---|---|---|---|
Market Cap | $4.4 Billion | 1/6 | KRYS $4.4B |
APLS $3.5B |
RYTM $3.5B |
DCPH $2.2B |
MGTX $503.3M |
RGNX $356.7M |
Gross Margin | 90% | 2/6 | DCPH 92% |
KRYS 90% |
RYTM 88% |
APLS 81% |
RGNX 49% |
MGTX -10% |
Profit Margin | 32% | 1/6 | KRYS 32% |
APLS -33% |
RGNX -100% |
DCPH -100% |
RYTM -100% |
MGTX -100% |
EBITDA margin | 27% | 1/6 | KRYS 27% |
APLS -38% |
DCPH -105% |
RYTM -132% |
RGNX -257% |
MGTX -367% |
Quarterly Revenue | $83.8 Million | 2/6 | APLS $176.6M |
KRYS $83.8M |
DCPH $45.0M |
RYTM $33.3M |
RGNX $24.2M |
MGTX $10.9M |
Quarterly Earnings | $27.2 Million | 1/6 | KRYS $27.2M |
MGTX -$39.3M |
RYTM -$45.0M |
DCPH -$45.1M |
APLS -$57.4M |
RGNX -$59.6M |
Quarterly Free Cash Flow | $57.8 Million | 1/6 | KRYS $57.8M |
APLS $34.1M |
RYTM $14.8M |
MGTX -$22.0M |
RGNX -$40.9M |
DCPH -$54.7M |
Trailing 4 Quarters Revenue | $241.5 Million | 2/6 | APLS $675.9M |
KRYS $241.5M |
DCPH $174.9M |
RYTM $112.5M |
RGNX $84.3M |
MGTX $13.9M |
Trailing 4 Quarters Earnings | $52.4 Million | 1/6 | APLS $176.6M |
KRYS $83.8M |
DCPH $45.0M |
RYTM $33.3M |
RGNX $24.2M |
MGTX $10.9M |
Quarterly Earnings Growth | 182% | 1/6 | KRYS 182% |
APLS 59% |
MGTX 11% |
RGNX 4% |
DCPH 2% |
RYTM -2% |
Annual Earnings Growth | 133% | 1/6 | KRYS 133% |
APLS 51% |
MGTX 34% |
RGNX 14% |
DCPH -4% |
RYTM -41% |
Quarterly Revenue Growth | 0% | 5/6 | MGTX 114% |
APLS 78% |
RYTM 48% |
DCPH 35% |
KRYS 0% |
RGNX -16% |
Annual Revenue Growth | 0% | 5/6 | MGTX 173% |
APLS 76% |
RYTM 40% |
DCPH 23% |
KRYS 0% |
RGNX -5% |
Cash On Hand | $374.0 Million | 2/6 | APLS $396.9M |
KRYS $374.0M |
MGTX $122.9M |
DCPH $91.2M |
RGNX $56.6M |
RYTM $47.5M |
Short Term Debt | $1.3 Million | 5/6 | RGNX $7.7M |
APLS $6.8M |
MGTX $4.2M |
DCPH $3.6M |
KRYS $1.3M |
RYTM -$0 |
Long Term Debt | $0 | 5/6 | APLS $104.7M |
RGNX $76.3M |
DCPH $21.4M |
RYTM $4.0M |
KRYS $0 |
MGTX $0 |
PE | 83.10 | 1/6 | KRYS 83.10 |
RGNX -1.00 |
APLS -1.00 |
DCPH -1.00 |
RYTM -1.00 |
MGTX -1.00 |
PS | 18.02 | 3/6 | MGTX 36.13 |
RYTM 31.45 |
KRYS 18.02 |
DCPH 12.65 |
APLS 5.25 |
RGNX 4.23 |
PB | 4.91 | 5/6 | RYTM 23.17 |
APLS 14.96 |
DCPH 7.00 |
MGTX 5.26 |
KRYS 4.91 |
RGNX 1.18 |
PC | 11.64 | 3/6 | RYTM 74.47 |
DCPH 24.26 |
KRYS 11.64 |
APLS 8.94 |
RGNX 6.30 |
MGTX 4.10 |
Liabilities to Equity | 0.11 | 6/6 | RYTM 18.80 |
APLS 2.80 |
MGTX 2.13 |
RGNX 0.72 |
DCPH 0.33 |
KRYS 0.11 |
ROA | 0.05 | 1/6 | KRYS 5% | APLS -28% | MGTX -29% | DCPH -45% | RGNX -46% | RYTM -72% |
ROE | 0.06 | 1/6 | KRYS 6% |
DCPH -60% |
RGNX -79% |
MGTX -92% |
APLS -105% |
RYTM -2320% |
Current Ratio | 10.18 | 1/6 | KRYS 10.18 |
DCPH 4.01 |
RGNX 2.38 |
RYTM 1.72 |
MGTX 1.47 |
APLS 1.36 |
Quick Ratio | 6.10 | 1/6 | KRYS 83.10 |
RGNX -1.00 |
APLS -1.00 |
DCPH -1.00 |
RYTM -1.00 |
MGTX -1.00 |
Long Term Debt to Equity | 0.00 | 5/6 | APLS} 0.44 |
RYTM} 0.36 |
RGNX} 0.25 |
DCPH} 0.07 |
KRYS} 0.00 |
MGTX} 0.00 |
Debt to Equity | 0.00 | 6/6 | APLS 0.47 |
RYTM 0.36 |
RGNX 0.28 |
DCPH 0.08 |
MGTX 0.04 |
KRYS 0.00 |
Burn Rate | -13.92 | 6/6 | APLS 6.27 |
MGTX 3.04 |
DCPH 1.95 |
RYTM 1.05 |
RGNX 0.88 |
KRYS -13.92 |
Cash to Cap | 0.09 | 4/6 | MGTX 0.24 |
RGNX 0.16 |
APLS 0.11 |
KRYS 0.09 |
DCPH 0.04 |
RYTM 0.01 |
CCR | 2.13 | 1/6 | KRYS 2.13 |
DCPH 1.21 |
RGNX 0.69 |
MGTX 0.56 |
RYTM -0.33 |
APLS -0.59 |
EV to EBITDA | 177.39 | 1/6 | KRYS} 177.39 |
RGNX} -6.19 |
MGTX} -9.61 |
DCPH} -45.43 |
APLS} -48.28 |
RYTM} -79.64 |
EV to Revenue | 16.48 | 3/6 | RYTM 31.06 |
MGTX 27.61 |
KRYS 16.48 |
DCPH 12.27 |
APLS 4.82 |
RGNX 4.56 |